Literature DB >> 28251404

The enhancement of antibody concentration and achievement of high cell density CHO cell cultivation by adding nucleoside.

Yasuhiro Takagi1,2, Takuya Kikuchi2, Ryuta Wada2, Takeshi Omasa3,4.   

Abstract

Recently, with the dramatic increase in demand for therapeutic antibodies, Chinese hamster ovary (CHO) cell culture systems have made significant progress in recombinant antibody production. Over the past two decades, recombinant antibody productivity has been improved by more than 100-fold. Medium optimization has been identified as an important key approach for increasing product concentrations. In this study, we evaluated the effects of deoxyuridine addition to fed-batch cultures of antibody-expressing CHO cell lines. Furthermore, we investigated the effects of combined addition of deoxyuridine, thymidine, and deoxycytidine. Our results suggest that addition of these pyrimidine nucleosides can increase CHO cell growth, with no significant change in the specific production rate. As a result of the increased cell growth, the antibody concentration was elevated and we were able to achieve more than 9 g/L during 16 days of culture. Similar effects of nucleoside addition were observed in fed-batch cultures of a Fab fragment-expressing CHO cell line, and the final Fab fragment concentration was more than 4 g/L. This nucleoside addition strategy could be a powerful platform for efficient antibody production.

Entities:  

Keywords:  Cell culture medium; Chinese hamster ovary (CHO) cell; Nucleoside; Therapeutic antibody

Year:  2017        PMID: 28251404      PMCID: PMC5461242          DOI: 10.1007/s10616-017-0066-7

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  45 in total

1.  Strategies for selecting recombinant CHO cell lines for cGMP manufacturing: realizing the potential in bioreactors.

Authors:  Alison J Porter; Alan J Dickson; Andrew J Racher
Journal:  Biotechnol Prog       Date:  2010 Sep-Oct

Review 2.  Production of recombinant protein therapeutics in cultivated mammalian cells.

Authors:  Florian M Wurm
Journal:  Nat Biotechnol       Date:  2004-11       Impact factor: 54.908

3.  Combined approach of NMR and chemometrics for screening peptones used in the cell culture medium for the production of a recombinant therapeutic protein.

Authors:  Ying Luo; Guoxiang Chen
Journal:  Biotechnol Bioeng       Date:  2007-08-15       Impact factor: 4.530

4.  Comparative transcriptional analysis of mouse hybridoma and recombinant Chinese hamster ovary cells undergoing butyrate treatment.

Authors:  Marcela De Leon Gatti; Katie F Wlaschin; Peter Morin Nissom; Miranda Yap; Wei-Shou Hu
Journal:  J Biosci Bioeng       Date:  2007-01       Impact factor: 2.894

5.  Overexpression of GADD34 enhances production of recombinant human antithrombin III in Chinese hamster ovary cells.

Authors:  Takeshi Omasa; Takashi Takami; Tomoshi Ohya; Eriko Kiyama; Tetsuji Hayashi; Hiroko Nishii; Hideo Miki; Kaoru Kobayashi; Kohsuke Honda; Hisao Ohtake
Journal:  J Biosci Bioeng       Date:  2008-12       Impact factor: 2.894

6.  Biopharmaceutical benchmarks 2014.

Authors:  Gary Walsh
Journal:  Nat Biotechnol       Date:  2014-10       Impact factor: 54.908

7.  Effects of variations in nucleoside pool sizes on comparisons of the incorporation of [3H]thymidine into isolated rat liver cells.

Authors:  G R Russell; E J Partick
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

8.  Enhanced antibody production of human-human hybridomas by retinoic acid.

Authors:  Y Inoue; M Fujisawa; M Shoji; S Hashizume; Y Katakura; S Shirahata
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

9.  Advances in animal cell recombinant protein production: GS-NS0 expression system.

Authors:  L M Barnes; C M Bentley; A J Dickson
Journal:  Cytotechnology       Date:  2000-02       Impact factor: 2.058

Review 10.  Advances in recombinant antibody manufacturing.

Authors:  Renate Kunert; David Reinhart
Journal:  Appl Microbiol Biotechnol       Date:  2016-03-03       Impact factor: 4.813

View more
  7 in total

1.  Improvement of growth rates through nucleoside media supplementation of CHO clones.

Authors:  Carly Morrison; Kalpanie Bandara; Wenge Wang; Lin Zhang; Bruno Figueroa
Journal:  Cytotechnology       Date:  2019-05-21       Impact factor: 2.058

2.  Improving titer while maintaining quality of final formulated drug substance via optimization of CHO cell culture conditions in low-iron chemically defined media.

Authors:  Jianlin Xu; Matthew S Rehmann; Xuankuo Xu; Chao Huang; Jun Tian; Nan-Xin Qian; Zheng Jian Li
Journal:  MAbs       Date:  2018-02-20       Impact factor: 5.857

3.  Biomanufacturing evolution from conventional to intensified processes for productivity improvement: a case study.

Authors:  Jianlin Xu; Xuankuo Xu; Chao Huang; James Angelo; Christopher L Oliveira; Mengmeng Xu; Xia Xu; Deniz Temel; Julia Ding; Sanchayita Ghose; Michael C Borys; Zheng Jian Li
Journal:  MAbs       Date:  2020-01-01       Impact factor: 5.857

Review 4.  Developments and opportunities in continuous biopharmaceutical manufacturing.

Authors:  Ohnmar Khanal; Abraham M Lenhoff
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

5.  Generation and Characterization of Stable Redox-Reporter Mammalian Cell Lines of Biotechnological Relevance.

Authors:  Karen Perelmuter; Inés Tiscornia; Marcelo A Comini; Mariela Bollati-Fogolín
Journal:  Sensors (Basel)       Date:  2022-02-09       Impact factor: 3.576

6.  Rich production media as a platform for CHO cell line development.

Authors:  Yong Jae Kim; Sang Kyul Han; Seongtae Yoon; Chan Wha Kim
Journal:  AMB Express       Date:  2020-05-15       Impact factor: 3.298

7.  A Metabolomics Approach to Increasing Chinese Hamster Ovary (CHO) Cell Productivity.

Authors:  Grace Yao; Kathryn Aron; Michael Borys; Zhengjian Li; Girish Pendse; Kyongbum Lee
Journal:  Metabolites       Date:  2021-11-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.